Other Secondary Carnitine Deficiency (ICD-10-CM Code: E71.448)

Name of the Condition

• Other secondary carnitine deficiency.

Summary

Other secondary carnitine deficiency is a condition where carnitine levels are reduced due to external factors, such as underlying diseases, medications, or dietary issues, rather than a primary genetic defect. Carnitine is essential for fatty acid metabolism and energy production, and its deficiency can disrupt cellular processes, particularly affecting tissues like the heart and muscles. This condition may lead to systemic complications if untreated.

Causes

This disorder is caused by factors that reduce carnitine availability or increase its utilization, such as chronic kidney disease, certain medications (e.g., valproic acid), malnutrition, or metabolic stress. Unlike primary carnitine deficiency, it is not inherited but develops secondary to another condition or exposure.

Risk Factors

• Chronic kidney disease or dialysis.
• Use of medications that deplete carnitine (e.g., valproic acid).
• Malnutrition or poor dietary intake.
• Metabolic stress from illness or surgery.
• Certain genetic disorders affecting other metabolic pathways.

Symptoms

• Muscle weakness or fatigue.
• Hypotonia (reduced muscle tone).
• Cardiomyopathy (heart muscle disease).
• Recurrent hypoglycemia (low blood sugar).
• Developmental delays or regression.
• Metabolic crises, including hypoketotic hypoglycemia.

Diagnosis

Diagnosis involves biochemical testing to measure carnitine levels in blood or urine, often revealing deficiencies or abnormal ratios. Clinical evaluation of underlying conditions or exposures is also critical. Additional tests may assess organ function (e.g., cardiac or renal) to identify contributing factors.

Treatment Options

Treatment focuses on addressing the underlying cause, such as adjusting medications, managing kidney disease, or improving nutrition. Carnitine supplementation may be used to restore levels, though this is tailored to the specific etiology. Supportive care for symptoms (e.g., cardiac or metabolic support) is often necessary.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and timeliness of intervention. Early treatment of reversible factors (e.g., medication adjustment or nutritional support) can improve outcomes. Regular monitoring of carnitine levels, organ function, and symptom management is essential for long-term follow-up.

Complications

• Progressive muscle weakness or cardiomyopathy.
• Recurrent metabolic crises (e.g., hypoglycemia).
• Developmental delays or regression if untreated.
• Organ dysfunction (e.g., renal or hepatic) due to underlying conditions.

Lifestyle & Prevention

• Maintain a balanced diet with adequate protein and nutrients.
• Avoid medications known to deplete carnitine unless medically necessary.
• Manage chronic conditions (e.g., kidney disease) with regular medical care.
• Monitor for symptoms and seek prompt evaluation if they occur.

When to Seek Professional Help

Seek medical attention if you experience unexplained muscle weakness, fatigue, or signs of metabolic distress (e.g., dizziness, confusion). Prompt evaluation is critical if you have a history of conditions or medications associated with carnitine deficiency.

Tips for Medical Coders

Document the underlying cause or contributing factor (e.g., chronic kidney disease, medication use) to support the diagnosis of other secondary carnitine deficiency. Ensure clinical correlation with biochemical testing (e.g., carnitine levels) and specify any relevant exposures or comorbidities.